In this study we tested the predictive accuracy of the baseline serum cystatin C levels as a tool to predict the occurrence of renal failure, defined as two different levels of GFR impairment, in patients receiving platinum-based chemotherapy. This evidence concerns the gene CST3 and Renal insufficiency.